Exocrine Pancreatic Insufficiency Treatment Market: Advancements in Digestive Health Solutions up to
The Exocrine Pancreatic Insufficiency (EPI) Treatment market focuses on therapies and solutions that aid in managing EPI, a condition characterized by the pancreas’s inability to produce enough digestive enzymes. This deficiency leads to malabsorption of nutrients, which can cause weight loss, diarrhea, and malnutrition. Treatment typically involves pancreatic enzyme replacement therapy (PERT) and dietary management to ensure proper digestion and absorption of nutrients.